These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
330 related articles for article (PubMed ID: 27436414)
1. Twin epidemics of new and prevalent hepatitis C infections in Canada: BC Hepatitis Testers Cohort. Janjua NZ; Yu A; Kuo M; Alvarez M; Cook D; Wong J; Tyndall MW; Krajden M BMC Infect Dis; 2016 Jul; 16():334. PubMed ID: 27436414 [TBL] [Abstract][Full Text] [Related]
2. Differing profiles of people diagnosed with acute and chronic hepatitis B virus infection in British Columbia, Canada. Binka M; Butt ZA; Wong S; Chong M; Buxton JA; Chapinal N; Yu A; Alvarez M; Darvishian M; Wong J; McGowan G; Torban M; Gilbert M; Tyndall M; Krajden M; Janjua NZ World J Gastroenterol; 2018 Mar; 24(11):1216-1227. PubMed ID: 29568202 [TBL] [Abstract][Full Text] [Related]
3. The Population Level Cascade of Care for Hepatitis C in British Columbia, Canada: The BC Hepatitis Testers Cohort (BC-HTC). Janjua NZ; Kuo M; Yu A; Alvarez M; Wong S; Cook D; Wong J; Grebely J; Butt ZA; Samji H; Ramji A; Tyndall M; Krajden M EBioMedicine; 2016 Oct; 12():189-195. PubMed ID: 27596150 [TBL] [Abstract][Full Text] [Related]
4. A syndemic approach to assess the effect of substance use and social disparities on the evolution of HIV/HCV infections in British Columbia. Butt ZA; Shrestha N; Wong S; Kuo M; Gesink D; Gilbert M; Wong J; Yu A; Alvarez M; Samji H; Buxton JA; Johnston JC; Cook VJ; Roth D; Consolacion T; Murti M; Hottes TS; Ogilvie G; Balshaw R; Tyndall MW; Krajden M; Janjua NZ; PLoS One; 2017; 12(8):e0183609. PubMed ID: 28829824 [TBL] [Abstract][Full Text] [Related]
5. Differences in risk factors for hepatitis B, hepatitis C, and human immunodeficiency virus infection by ethnicity: A large population-based cohort study in British Columbia, Canada. Binka M; Butt ZA; McKee G; Darvishian M; Cook D; Wong S; Yu A; Alvarez M; Samji H; Wong J; Krajden M; Janjua NZ Int J Infect Dis; 2021 May; 106():246-253. PubMed ID: 33771673 [TBL] [Abstract][Full Text] [Related]
6. Assessing Hepatitis C Burden and Treatment Effectiveness through the British Columbia Hepatitis Testers Cohort (BC-HTC): Design and Characteristics of Linked and Unlinked Participants. Janjua NZ; Kuo M; Chong M; Yu A; Alvarez M; Cook D; Armour R; Aiken C; Li K; Mussavi Rizi SA; Woods R; Godfrey D; Wong J; Gilbert M; Tyndall MW; Krajden M PLoS One; 2016; 11(3):e0150176. PubMed ID: 26954020 [TBL] [Abstract][Full Text] [Related]
7. Sero-prevalence of hepatitis B and C viral infections in Ghanaian HIV positive cohort: a consideration for their health care. Pappoe F; Hagan CKO; Obiri-Yeboah D; Nsiah P BMC Infect Dis; 2019 May; 19(1):380. PubMed ID: 31053100 [TBL] [Abstract][Full Text] [Related]
8. Role of primary T-cell immunodeficiency and hepatitis B coinfection on spontaneous clearance of hepatitis C: The BC Hepatitis Testers Cohort. Islam N; Krajden M; Gilbert M; Gustafson P; Yu A; Kuo M; Chong M; Alvarez M; Wong J; Tyndall MW; Janjua NZ J Viral Hepat; 2017 May; 24(5):421-429. PubMed ID: 27885757 [TBL] [Abstract][Full Text] [Related]
9. Prevalence of human immunodeficiency virus, hepatitis C virus, hepatitis B virus and syphilis among individuals attending anonymous testing for HIV in Luanda, Angola. Guimarães Nebenzahl H; Lopes A; Castro R; Pereira F S Afr Med J; 2013 Jan; 103(3):186-8. PubMed ID: 23472697 [TBL] [Abstract][Full Text] [Related]
10. Prevalence of infection with hepatitis B and C virus and coinfection with HIV in medical inpatients in Malawi. Nyirenda M; Beadsworth MB; Stephany P; Hart CA; Hart IJ; Munthali C; Beeching NJ; Zijlstra EE J Infect; 2008 Jul; 57(1):72-7. PubMed ID: 18555534 [TBL] [Abstract][Full Text] [Related]
11. HIV, Hepatitis B and C among people who inject drugs: high prevalence of HIV and Hepatitis C RNA positive infections observed in Delhi, India. Ray Saraswati L; Sarna A; Sebastian MP; Sharma V; Madan I; Thior I; Pulerwitz J; Tun W BMC Public Health; 2015 Jul; 15():726. PubMed ID: 26223866 [TBL] [Abstract][Full Text] [Related]
12. Viral hepatitis prevalence in patients with active and latent tuberculosis. Nooredinvand HA; Connell DW; Asgheddi M; Abdullah M; O'Donoghue M; Campbell L; Wickremasinghe MI; Lalvani A; Kon OM; Khan SA World J Gastroenterol; 2015 Aug; 21(29):8920-6. PubMed ID: 26269682 [TBL] [Abstract][Full Text] [Related]
13. Prevalence of HBV, HCV, HIV-1, 2 and HTLV-I/II infections among blood donors in a teaching hospital in the Central region of Saudi Arabia. El-Hazmi MM Saudi Med J; 2004 Jan; 25(1):26-33. PubMed ID: 14758374 [TBL] [Abstract][Full Text] [Related]
14. Hepatitis B and C serologic profiles of Canadian organ donors and recipients: retrospective 10-year review at a single center. Burton CE; Doucette KE; Mabilangan CA; Plitt SS; Lee BE; Preiksaitis JK Transpl Infect Dis; 2016 Aug; 18(4):520-8. PubMed ID: 27226204 [TBL] [Abstract][Full Text] [Related]
15. Incidence, risk factors, and prevention of hepatitis C reinfection: a population-based cohort study. Islam N; Krajden M; Shoveller J; Gustafson P; Gilbert M; Buxton JA; Wong J; Tyndall MW; Janjua NZ; Lancet Gastroenterol Hepatol; 2017 Mar; 2(3):200-210. PubMed ID: 28404135 [TBL] [Abstract][Full Text] [Related]
16. Prevalence of hepatitis B virus, hepatitis C virus, human immunodeficiency virus and Treponema pallidum infections in hospitalized patients before transfusion in Xiangya hospital Central South University, China from 2011 to 2016. Cao WW; Zhou RR; Ou X; Shi LX; Xiao CQ; Chen TY; Tan H; Fan XG; Li BJ; Li N BMC Infect Dis; 2018 Apr; 18(1):145. PubMed ID: 29606088 [TBL] [Abstract][Full Text] [Related]
17. Prevalence estimates of HIV, syphilis, hepatitis B and C among female sex workers (FSW) in Brazil, 2016. Ferreira-Júnior ODC; Guimarães MDC; Damacena GN; de Almeida WDS; de Souza-Júnior PRB; Szwarcwald CL; Medicine (Baltimore); 2018 May; 97(1S Suppl 1):S3-S8. PubMed ID: 29912817 [TBL] [Abstract][Full Text] [Related]
18. Co-infection assessment in HBV, HCV, and HIV patients in Western Saudi Arabia. Al-Mughales JA J Med Virol; 2016 Sep; 88(9):1545-51. PubMed ID: 26895691 [TBL] [Abstract][Full Text] [Related]
19. Will a quadruple multiplexed point-of-care screening strategy for HIV-related co-infections be feasible and impact detection of new co-infections in at-risk populations? Results from cross-sectional studies. Pai NP; Dhurat R; Potter M; Behlim T; Landry G; Vadnais C; Rodrigues C; Joseph L; Shetty A BMJ Open; 2014 Dec; 4(12):e005040. PubMed ID: 25510882 [TBL] [Abstract][Full Text] [Related]
20. Prevalence of hepatitis B and C viruses in HIV-positive patients in China: a cross-sectional study. Xie J; Han Y; Qiu Z; Li Y; Li Y; Song X; Wang H; Thio CL; Li T J Int AIDS Soc; 2016; 19(1):20659. PubMed ID: 26979535 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]